1. Home
  2. LCTX vs NNDM Comparison

LCTX vs NNDM Comparison

Compare LCTX & NNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.62

Market Cap

359.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCTX
NNDM
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
359.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LCTX
NNDM
Price
$1.65
$1.62
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.25
N/A
AVG Volume (30 Days)
1.3M
3.3M
Earning Date
11-06-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,816,000.00
$69,663,000.00
Revenue This Year
$6.32
N/A
Revenue Next Year
$124.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.05
26.75
52 Week Low
$0.37
$1.31
52 Week High
$2.09
$2.74

Technical Indicators

Market Signals
Indicator
LCTX
NNDM
Relative Strength Index (RSI) 43.84 38.14
Support Level $1.63 $1.68
Resistance Level $1.77 $1.90
Average True Range (ATR) 0.08 0.08
MACD -0.01 -0.02
Stochastic Oscillator 16.67 4.76

Price Performance

Historical Comparison
LCTX
NNDM

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

Share on Social Networks: